QUEBEC, Jan. 7 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc.,"Victhom" (TSX: VHB), announced today that it will participate in theOneMedPlace Finance Forum in San Francisco, CA on January 13 and 14, 2009.Nader Kameli, Chief Operating Officer of Victhom's Neurobionix division, willbe presenting on Tuesday, January 13 at 9:00 a.m. Pacific Time, at the SirFrancis Drake Hotel at 450 Powell Street. Information about the OneMedPlaceFinance Forum may be found at http://www.onemedplace.com.
Victhom has developed the Neurostep(R) System, an implantableneurostimulation device designed to restore mobility and independence forpatients with partial paralysis of the leg as a result of hemiparetic stroke.The Neurostep(R) System has been engineered to integrate with the body'snatural sensing and stimulation network and designed to closely mimic specificfunctions that have been interrupted or lost due to disease or injury. TheNeurostep(R) is an investigational medical device currently in human clinicalstudy in four clinical sites outside U.S. and is planned for marketintroduction in Europe late 2009.
Victhom discovers, develops and manufactures bionic devices involved inthe treatment of a variety of physical and physiological dysfunctions.Victhom's Neurobionix division focuses on the development andcommercialization of technologies and products involving implantable devicesthat feature neurosensing and neurostimulation components, integrated withartificial intelligence. Victhom's Biotronix division develops biomechatronicproducts to support or replace peripheral limbs in what is known as theorthotics and prosthetics market.
OneMedPlace is a virtual community of healthcare and life sciencecompanies. It has, for the first time, put in place the innovations that willshape the future of health and medicine emerging companies and technologiesseeking capital, distribution, visibility and resources to help finance, buildand grow, and investors and strategic partners looking for health and medicalinnovations to invest in, acquire, license, distribute, purchase or utilize.
Some of the statements made herein may constitute forward-lookingstatements. These statements relate to future events or our future financialperformance and involve known and unknown risks, uncertainties and otherfactors that may cause Victhom's actual results, performance or achievementsto be materially different from those expressed or implied by any of Victhom'sstatements. Actual events or results may differ materially. We disclaim anyintention, and assume no obligation, to update these forward-lookingstatements.
SOURCE VICTHOM HUMAN BIONICS INC.